tert-Butyl 4-(3-(ethoxycarbonyl)pyridin-2-yl)piperazine-1-carboxylate

Catalog No.: 
ACMHKG576
CAS No.: 
900183-95-1
Molecular Formula: 
C17H25N3O4
Molecular Weight: 
335.40
tert-Butyl 4-(3-(ethoxycarbonyl)pyridin-2-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$1001.001 week1 week
1g95%$2002.001 week1 week

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(3-(ethoxycarbonyl)pyridin-2-yl)piperazine-1-carboxylate
IUPAC Nametert-butyl 4-(3-(ethoxycarbonyl)pyridin-2-yl)piperazine-1-carboxylate
Molecular FormulaC17H25N3O4
Molecular Weight335.40
SMILESO=C(C1=CC=CN=C1N2CCN(C(OC(C)(C)C)=O)CC2)OCC
InChI KeyFTFQRHIAIMGSEK-UHFFFAOYSA-N
Synonym1-Boc-4-(3-ethoxycarbonyl-pyridin-2-yl)-piperazine;1-Piperazinecarboxylic acid, 4-[3-(ethoxycarbonyl)-2-pyridinyl]-, 1,1-dimethylethyl ester
CAS No.900183-95-1

Synthetic Route by SureRoute

1. ACMHKG576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7In Stock
  2. Plus
  3. ACPQMS082 route compound structure diagram
    ACPQMS0821452-94-4In Stock
  4. Then
  5. ACMHKG576 route product structure diagram
    ACMHKG576900183-95-1
Inquiry

2. ACMHKG576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7In Stock
  2. Plus
  3. ACXBHV436 route compound structure diagram
    ACXBHV43653087-78-8In Stock
  4. Then
  5. ACMHKG576 route product structure diagram
    ACMHKG576900183-95-1
Inquiry

3. ACMHKG576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMHKG576 route product structure diagram
    ACMHKG576900183-95-1
Inquiry

Comments (0)